ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (ACAD)

CUSIP: 004225108

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
170,450,287
Total 13F shares
137,820,078
Share change
-1,854,124
Total reported value
$3,700,427,361
Put/Call ratio
94%
Price per share
$26.85
Number of holders
197
Value change
-$451,990
Number of buys
99
Number of sells
79

Quarterly Holders Quick Answers

What is CUSIP 004225108?
CUSIP 004225108 identifies ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (ACAD) as of Q1 2019

As of 31 Mar 2019, ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (ACAD) was held by 197 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 137,820,078 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FIRST TRUST ADVISORS LP, OppenheimerFunds, Inc., Palo Alto Investors LP, and GREAT POINT PARTNERS LLC. This page lists 197 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.